SCHEMBL1758972

SCHEMBL1758972

CC(=O)c1ccc(-c2ccc3nc(CC=O)ccc3c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B1 P14061 2/20 0.41
▸ KIF11 P52732 1/20 0.40
▸ MAPT P10636 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ FFAR4 Q5NUL3 2/20 0.38
▸ LIPG Q9Y5X9 1/20 0.38
▸ ADORA3 P0DMS8 3/20 0.37
▸ GRM1 Q13255 1/20 0.37
▸ MAP4K4 O95819 1/20 0.36
▸ CSNK1G2 P78368 1/20 0.36
▸ CLK4 Q9HAZ1 1/20 0.36
▸ MKNK2 Q9HBH9 1/20 0.36
▸ MAP4K5 Q9Y4K4 1/20 0.36
▸ HTR2C P28335 1/20 0.36
▸ MCHR1 Q99705 1/20 0.36
▸ HDAC2 Q92769 1/20 0.36
▸ HDAC8 Q9BY41 1/20 0.36
▸ HDAC6 Q9UBN7 1/20 0.36
▸ CYP1A2 P05177 1/20 0.36
▸ CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1293407 0.77 HSD17B1 (0.46) HSD17B1KIF11MAPTSMN1; SMN2ADORA3
SCHEMBL1759076 0.76 CYP2A6 (0.44) HSD17B1KIF11MAPTSMN1; SMN2CYP1A2
SCHEMBL27887117 0.74 HSD17B1 (0.46) HSD17B1KIF11MAPTSMN1; SMN2ADORA3
SCHEMBL26327985 0.72 KMT2A (0.57) HSD17B1KIF11MAPTSMN1; SMN2XDH
SCHEMBL1641043 0.71 HRH3 (0.55) —
SCHEMBL1641044 0.71 HRH3 (0.55) —
SCHEMBL1293873 0.70 MAPT (0.57) HSD17B1KIF11MAPTSMN1; SMN2ADORA3
SCHEMBL266084 0.70 BACE1 (0.49) MAPTHDAC2CYP1A2
SCHEMBL14539003 0.70 NPC1 (0.66) MAPTSMN1; SMN2MAP4K4CSNK1G2CLK4
SCHEMBL18260221 0.68 MAPT (0.64) HSD17B1KIF11MAPTSMN1; SMN2HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2499127-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2012-09-19 — — EP disclosed
EP-2499115-A1 HEPATITIS C VIRUS INHIBITORS Bristol-Myers Squibb Company (US) 2012-09-19 — — EP disclosed
WO-2011059887-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-05-19 — — WO disclosed
WO-2011059850-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-05-19 — — WO disclosed
Send feedback